Global Lab Capabilities Pharma Biotech
|
|
|
- Scot Reynolds
- 9 years ago
- Views:
Transcription
1 Global Lab Capabilities Pharma Biotech NSF Health Sciences global network of laboratories delivers expert solutions to pharmaceutical, biotechnology and medical device companies in the areas of analytical testing, regulatory consulting, research and development, and regulatory submissions.
2 About NSF International NSF International is a global independent organization that writes standards, and tests and certifies products for the food, water and consumer goods industries to minimize adverse health effects and protect the environment (nsf.org). Founded in 1944, NSF is committed to protecting human health and safety worldwide. NSF International is a Pan American Health Organization/World Health Organization Collaborating Center on Food Safety, Water Quality and Indoor Environment. Our Services NSF supports the global pharmaceutical marketplace, including regulators, manufacturers and consumers of pharma, biotech, medical/combination devices and single-use systems, in the development of innovative products by providing expert support services from preclinical activities to post-market changes. Our global network of accredited labs and industry experts help bring safe products to market and assure that projects are completed to your satisfaction and on time. NSF has more than 2,100 experienced professionals including microbiologists, toxicologists, chemists, engineers and experts in public health. Our Labs Our global network of labs utilize QA systems and maintain strategic accreditations such as ISO/IEC Our Bristol lab operates as an independent GLP and GMP contract laboratory, which is U.S. FDA registered and U.S. DEA licensed. Other lab accreditations include INMETRO/MAPA/REBLAS/ANVISA (Brazil); CMA/CMAF (China); and Authorized laboratory for Quality Control in Pharmaceutical Members of Official Networks Laboratory by the National Institute of Health-INS (Peru). For accreditations specific to each lab, please see the lab profiles. NSF s scientific knowledge, technical expertise, lab capabilities and customer service enable us to manage the most challenging projects and to assure that your projects are completed to your satisfaction and on time.
3 Bristol, CT Shanghai, China Lima, Peru Porto Alegre, Brazil NSF Locations NSF Partner Locations Services NSF delivers expert support services from preclinical activities to phase I-IV clinical trials, pharmaceutical development, bioanalytical, protein characterization, biosafety and quality control testing of small and large molecules, raw materials, finished products, containers and utilities. Preclinical - The preclinical tests evaluates safety parameters and effectiveness of pharmaceuticals, through toxicology studies conducted to determine the degree of toxicity and potential reversibility or irreversibility of a chemical substance, to establish the relationship between dose and adverse effects, and to provide information on target organs and target functions. This allows a meaningful assessment of the data obtained and a scientifically supported extrapolation of the effects to the human situation. Clinical NSF provides analysis of small molecule, protein and oligonucleotide therapeutics in plasma, serum and urine through all stages of clinical development. Our scientists routinely validate methods to FDA and other regulatory guidance. NSF is able to identify and analyze for drug metabolites. CMC Analytical NSF develops and validates methods for drug purity, drug content, degradation products and impurities. We routinely perform these methods, compendial methods and microbiological testing in GMP compliance. Our labs perform extractable and leachables studies to assess risk from container closure systems and process equipment.
4 Preclinical Brazil USA Peru China Toxicology test design Toxicological testing Toxicological evaluation Formulation development Formulation analysis Bioanalytical method development and validation (animal) Plasma (animal) specimen analysis Metabolite Identification Clinical Bioanalytical method development and validation (human) Plasma (human) specimen analysis Metabolite identification CMC Analytical Develop and validate methods for assays and impurities/degradants Analytical testing to support stability Forced degradation Compendia testing (USP, EP, BP) Identification analysis for active pharmaceutical ingredient Microbiological testing Extractables from container closure system Leachables from container closure system into drug product Drug product release testing Dissolution testing Visible and sub visible particles Sampling lots Pharmaceutical packaging compatibility
5
6 The right people. The right solution. The first time. LPH LPH
7 Lab Profile NSF Bioensaios Porto Alegre, Brazil Services: Physical-Chemical Testing Studies in compliance with GLP following ANVISA and ICH guidelines Method development and validation for assay, impurities and degradation products for drugs in compliance with GLP Compendia testing (USP, EP, BP) Forced degradation testing Investigation of impurities: Identification of unknown impurities and degradation products Toxicological Testing Testing following ANVISA, FDA, EMA, ICH and OECD guidance and in compliance with GLP Testing development Microbiological Testing Testing in according to USP and European pharmacopeia Size: 12,000 square feet (1,115 square meters) Established: 1990 Employees: 70+ Accreditations: GLP OECD ISO/IEC (CGCRE - Coordenação Geral de Acreditação do INMETRO) MAPA - Agriculture Ministry (Veterinary Medical) ANVISA/REBLAS - Health Agency Site Manager: Ellen Martha Pritsch, Director of Business Operations Address: Rua Palermo CEP Viamão - Brazil Phone: (55) [email protected] The right people. The right solution. The first time. LPH
8 Lab Profile NSF Health Sciences Bristol, CT, USA Services: Preclinical and Clinical Support Services for Pharmaceuticals Preclinical study design, consultation and monitoring Preclinical formulation development and analysis Bioanalytical methods development, validation and sample analysis GMP Analytical Testing for Pharmaceuticals and Medical Devices Method development and validation for assay, impurities and degradation products for drugs and combination medical devices Support stability studies, process development and release of finished product USP testing Identification of unknown impurities and degradation products Extractables and Leachables Testing for Pharmaceuticals, Medical Devices and Single-Use Manufacturing Equipment Material Assessment and study design Controlled extraction studies Leachables analysis for drug product container closure systems Size: 15,000 square feet (1,400 square meters) Established: 2000 Employees: 30 Accreditations: GLP and GMP contract laboratories U.S. FDA registered U.S. DEA licensed Site Manager: Kurt Moyer, Ph.D., Director of Research Address: 719 Middle Street, Bristol, CT USA Phone: The right people. The right solution. The first time. LPH
9 Lab Profile NSF INASSA Lima, Peru Services: Physicochemical and Microbiological Testing for Pharmaceutical Dosage Forms Solid, semisolid and liquid According to regulations: USP / BP / EP Physicochemical Analysis Organoleptic analysis Basic analysis (ph, volume, average weight, density) Quantitative analysis of active ingredients APIs by HPLC, GC, UV-VIS, IR, AAS, Potentiometry, Volumetry and Polarimetry Identification analysis of APIs by TLC, IR and Chemical Reactions Complementary analysis of dosage forms Dissolution, Disintegration, Visible strange particles, Count test of Subvisibles particles for obstruction of light and Microscopy, content of water for KF Microbiological Analysis According to regulation: USP / BP / EP: Standard plate count, test for specific microorganisms, sterility test, Microbiological assays of antibiotics, Bacterial Endotoxins test, Antimicrobial effectiveness test, growth promotion testing media Size: According to AOAC, PREN and NF EN 1040: Bacterial activity in soaps, Disinfectants, Germicidal and Detergents actions and Basic Quantitative assay of bactericidal activity of chemical disinfectants and antiseptics 33,260 square feet (3,090 square meters) Established: 1981 Employees: 220+ Accreditations: Authorized laboratory for Quality Control in Pharmaceutical Members of Official Networks Laboratory in Peru by the National Institute of Health (INS). ISO/IEC INACAL (Instituto Nacional de Calidad) Site Manager: Carmen Catter, General Manager Address: Av. La Marina 3035 San Miguel Lima Phone: 511( ) [email protected] The right people. The right solution. The first time. LPH
10 Lab Profile NSF Shanghai Testing Company Shanghai, China Services: Extractables and Leachables Testing for Pharmaceutical Packaging Materials and Medical Devices Material assessment and study design Controlled extraction studies Leachables analysis for drug product container closure systems Compatibility Studies Between Pharmaceutical Packaging and Pharmaceuticals Guidelines of Evaluating Compatibility between Pharmaceutical Packaging and Pharmaceuticals (YBB ) Guidelines of Evaluating Compatibility between Chemical Injectables and Polymer Packaging Guidelines of Evaluating Compatibility between Injectables and Glass Packaging cgmp Audit and Analytical Testing for Dietary Supplements cgmp audited following FDA 21 CFR 111 for dietary supplement industry Test method development and validation for ingredient and contaminants in dietary supplements CHP/USP/EP testing Size: 13,600 square feet (1,260 square meters) Established: 2010 Employees: 30 Accreditations: CNAS (ISO/IEC 17025) CMA (China Metrology Accreditation) CMAF (China Metrology Accreditation for Food) Site Manager: Ms. Dongjing Liu, Laboratory Site Manager Address: Unit D/F, 1 Floor, Building 10 Pujiang Intelligence Valley, 1188 Lian Hang Road Shanghai, P.R. China Phone: [email protected] The right people. The right solution. The first time. LPH
C 5. chemical development contract research custom synthesis cgmp API manufacturing commercial production. Welcome to
C 5 chemical development contract research custom synthesis cgmp API manufacturing commercial production Welcome to ChemCon Company profile Company profile ChemCon offers outstanding chemical services
Catalog. Global Education. and Training. Global Expertise Trusted Standards Improved Health
Global Education Catalog 2013 2014 and Training Global Expertise Trusted Standards Improved Health USP s mission is to improve global health through public standards and related programs that help ensure
Bachelor of Science in Pharmaceutical Sciences (BSPS) Program Overview and Internship Requirements
Bachelor of Science in Pharmaceutical Sciences (BSPS) Program Overview and Internship Requirements Pharmaceutical Sciences Applied sciences that underlie the practice of pharmacy the development, manufacture,
Working with ICH Quality Guidelines - the Canadian Perspective
Working with ICH Quality Guidelines the Canadian Perspective Krishnan Tirunellai, Ph. D. Bureau of Pharmaceutical Sciences Therapeutic Products Directorate Health Canada December 3, 2008 Outline Introduction
NEW CHEMICAL ENTITIES
NEW CHEMICAL ENTITIES PIONEERING PARTNER FOR PEPTIDES With more than 40 years of expertise in peptide synthesis, a track record in process development, large-scale manufacturing and outstanding product
Guidance for Industry
Guidance for Industry INDs for Phase 2 and Phase 3 Studies Chemistry, Manufacturing, and Controls Information U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation
EXTRACTABLES AND LEACHABLES FOR MEDICAL DEVICES: MEETING THE 510 (k) REQUIREMENTS
EXTRACTABLES AND LEACHABLES FOR MEDICAL DEVICES: MEETING THE 510 (k) REQUIREMENTS BIOGRAPHICAL NOTE Kurt Moyer, Ph.D. Director of Research, NSF Pharmalytica Bristol, Connecticut, USA 06010 Tel: 1(860)
Post-Approval Change Management: Challenges and Opportunities An FDA Perspective
CMC Workshop From Drug Development to Global Supply to Patients April 15-17, 2013, Washington, DC Post-Approval Change Management: Challenges and Opportunities An FDA Perspective Christine M. V. Moore,
Blood, Plasma, and Cellular Blood Components INTRODUCTION
Blood, Plasma, and Cellular Blood Components INTRODUCTION This chapter of the Guideline provides recommendations to Sponsors of Requests for Revision for new monographs for blood, plasma, and cellular
SERVICES FOR. Devices and Combination Products
SERVICES FOR Devices and Combination Products How to Contact Us U.S. FACILITIES / CLIENT SERVICES St. Paul 2540 Executive Drive St. Paul, MN 55120 FAX 651.675.2005 Atlanta 1265 Kennestone Circle Marietta,
International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation
International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation Ludwig Huber, Ph.D. [email protected] Overview GMP requirements for Quality Control laboratories
Microbiology and Auditing. Don Singer
Microbiology and Auditing Don Singer ASQ Northeast Pharmaceutical GMP/Quality Conference 2011 Through the eyes of a Microbiologist Microbiology Audit = Inspection / Investigation Systematic Auditing Planning
Implementing New USP Chapters for Analytical Method Validation
Implementing New USP Chapters for Analytical Method Validation March 2010 Ludwig Huber Fax.: +49 7243 602 501 E-mail: [email protected] Today s Agenda Handling Method Changes vs. Adjustments
Regulations for Handling Samples and Laboratory Testing from R&D through Phase III Clinical Trials
Regulations for Handling Samples and Laboratory Testing from R&D through Phase III Clinical Trials Ron Hinkel, Director Quality Systems BioReliance Inc. Patti Rossman, President Globiox Purpose Keep pace
Valentina Gualato, Ph.D. Process Development Scientist
COMPANY PRESENTATION Quality and Innovation Valentina Gualato, Ph.D. Process Development Scientist MISSION areta international is a biotech company dedicated to the contract development and manufacturing
Overview of Drug Development: the Regulatory Process
Overview of Drug Development: the Regulatory Process Roger D. Nolan, PhD Director, Project Operations Calvert Research Institute November, 2006 Adapted from course taught by Cato Research Background: Roger
Expectations for Data to Support Clinical Trial Drugs
Expectations for Data to Support Clinical Trial Drugs Presentation to: APEC Advanced Workshop on Review of Drug Development in Clinical Trials Bangkok Thailand Feb 2-6 2009 Willem Stevens Ph.D., Chief
Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE
Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE Dr. Fulvio CARLOTTI, GNOSIS SpA, Corporate QA Director September 26, 2014 Scope of GMP GMP compliance
Cleaning Validation in Active pharmaceutical Ingredient manufacturing plants
Cleaning Validation in Active pharmaceutical Ingredient manufacturing plants September 1999 Table of contents 1. Foreword...... 2 2. Objective...... 3 3. Scope........ 4 4. Potential residues... 5 5. Current
Biotechpharma company profile
Biotechpharma company profile October 2013 1 History 2004 Biotechpharma UAB established as a proteomic research company in Vilnius, Lithuania 2005 Company became a member of UK s Northway group, investing
How To Test For Leachables
Current FDA Perspective on Leachable Impurities in Parenteral and Ophthalmic Drug products AAPS Workshop on Pharmaceutical Stability Scientific and Regulatory Considerations for Global Drug Development
Extemporaneously Prepared Early Phase Clinical Trial Materials
Extemporaneously Prepared Early Phase Clinical Trial Materials Richard Hoffman, MS, RAC Eli Lilly & Co. Regulatory Advisor International Consortium for Innovation & Quality in Pharmaceutical Development
PHARMACEUTICAL REFERENCE STANDARDS
PHARMACEUTICAL REFERENCE STANDARDS 11 th International Symposium organised by the European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe 3-4 September 2012, Strasbourg,
Step-by-Step Analytical Methods Validation and Protocol in the Quality System Compliance Industry
Step-by-Step Analytical Methods Validation and Protocol in the Quality System Compliance Industry BY GHULAM A. SHABIR Introduction Methods Validation: Establishing documented evidence that provides a high
Introduction to Enteris BioPharma
Introduction to Enteris BioPharma Enteris BioPharma Intelligent Solutions for Oral Drug Delivery Privately held, New Jersey based biotech company Owned solely by Victory Park Capital, a large Chicago based
Pharmaceuticals Production Services Boehringer Ingelheim. Our expertise in world-class contract manufacturing for your success
Pharmaceuticals Production Services Boehringer Ingelheim Our expertise in world-class contract manufacturing for your success Successful partnership Dr Wolfram Carius Head of Corporate Division Pharmaceuticals
USP s mission is to improve global health through public. standards and related programs that help ensure the quality,
2015 Catalog USP s mission is to improve global health through public standards and related programs that help ensure the quality, safety, and benefit of medicines and foods. 2 Courses listed as of January
Library Guide: Pharmaceutical GMPs
Library Guide: Pharmaceutical GMPs Table of Contents Overview...3 Courses Listed by Functional Area... 4 Course Descriptions: A Step-by-Step Approach to Process Validation (PHDV79)... 7 A Tour of the FDA
GMP Pharma BV. Netherlands
GMP Pharma BV Netherlands Connecting the European & Indian Pharmaceutical, Biotechnology and Biopharmaceutical Industry for parallel growth and solicitation. About Us: GMP Pharma BV is a multisource organization
Guidance for Industry
Guidance for Industry Changes to an Approved NDA or ANDA U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) April 2004 CMC Revision
Annex 7 Guidelines on pre-approval inspections
World Health Organization WHO Technical Report Series, No. 902, 2002 Annex 7 Guidelines on pre-approval inspections 1. General 94 2. Glossary 94 3. Objectives 95 4. Priorities 96 5. Preparation for the
Annex 6. Guidance on variations to a prequalified product dossier. Preface
Annex 6 Guidance on variations to a prequalified product dossier Preface This guidance document was technically and structurally inspired by the Guideline on dossier requirements for type IA and IB notifi
GLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group [email protected]
GLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group [email protected] Common Misconception Good Laboratory Practices 1) A quality system concerned with the organizational process
COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS
COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS Primer CONTENTS INTRODUCTION...3 QUALITY AND COMPLIANCE IN QUALITY CONTROL LABORATORIES...5 Compliance
Guidance for Industry
5 Guidance for Industry Drug Stability Guidelines (This version of the guidance replaces the version that was made available in December 1990. This guidance document has been revised to correct the contact
Workshop B Control Strategy
ICH-GCG ASEAN Workshop B Control Strategy Jean-Louis ROBERT, Ph.D. National Health Laboratory, Luxembourg Chair-person ICH IWG Q8, Q9, Q10 Kuala Lumpur, 26-28 July 2010 International Conference on Harmonisation
Presented at: Jefferies 2015 Global Healthcare Conference
Presented at: Jefferies 2015 Global Healthcare Conference Agenda 1 Overview & Service Platforms 2 Adaptability, Scalability & Expansion Plans 3 Best Practices 4 Blue Chip Customer Base 5 Roadmap of Evolution
Micromyx. Micromyx. A Microbiology Services Company. Lab Services Research - Consulting -
A Microbiology Services Company Lab Services Research - Consulting - Regulatory Company description is a microbiology services company specializing in antiinfective discovery and development for the pharmaceutical,
Elastomeric Components for Pharmaceutical Applications - Actual Quality Trends - Claudia Petersen. -Senior Manager Biotechnology-
Elastomeric Components for Pharmaceutical Applications - Actual Quality Trends - Claudia Petersen -Senior Manager Biotechnology- 2005 by West Pharmaceutical Services, Inc., Lionville, PA All rights reserved.
IMPURITIES IN NEW DRUG PRODUCTS
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE IMPURITIES IN NEW DRUG PRODUCTS Q3B(R2) Current
PEOPLE > SCIENCE > SOLUTIONS
PEOPLE > SCIENCE > SOLUTIONS Our difference Our foundation Our focus ANALYTICAL CHEMISTRY & MATERIALS CHARACTERIZATION EFFICACY (Functional testing) BIOCOMPATIBILITY (in vivo & in vitro toxicology) CLINICAL
The Facts on Equine Drug Testing
The Facts on Equine Drug Testing CONTACT Travis Mays, MS Interim Section Head Analytical Chemistry, Drug Testing Laboratory Toxicology Laboratory 979.845.3414 tmays@ LIMITATIONS IN DRUG TESTING While advancements
Guidance for Industry
Guidance for Industry Content and Format of Investigational New Drug Applications (INDs) for Phase 1 Studies of Drugs, Including Well-Characterized, Therapeutic, Biotechnology-derived Products Center for
Guidance for Industry
Guidance for Industry Investigating Out-of-Specification (OOS) Test Results for Pharmaceutical Production U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation
Highly Potent APIs The right platform, people and procedures for successful development and manufacturing
Pharma&Biotech Highly Potent APIs The right platform, people and procedures for successful development and manufacturing Custom Manufacturing and Development Services for Highly Potent APIs Pharma&Biotech
ICH Topic Q 1 A Stability Testing Guidelines: Stability Testing of New Drug Substances and Products
The European Agency for the Evaluation of Medicinal Products Human Medicines Evaluation Unit CPMP/ICH/380/95 ICH Topic Q 1 A Stability Testing Guidelines: Stability Testing of New Drug Substances and Products
Global experts in Remediation, Auditing, GMP Compliance, Education and Regulatory Affairs for the Pharma and Biotech Industry
Global experts in Remediation, Auditing, GMP Compliance, Education and Regulatory Affairs for the Pharma and Biotech Industry www.nsf.org The right people. The right solution. The first time. Quality Systems
Engineering Nanomedical Systems
BME 695 November 8, 2011 Engineering Nanomedical Systems Lecture 15 GMP and issues of quality control manufacture of nanodelivery systems James F. Leary, Ph.D. SVM Endowed Professor of Nanomedicine Professor
GUIDELINES FOR THE VALIDATION OF ANALYTICAL METHODS FOR ACTIVE CONSTITUENT, AGRICULTURAL AND VETERINARY CHEMICAL PRODUCTS.
GUIDELINES FOR THE VALIDATION OF ANALYTICAL METHODS FOR ACTIVE CONSTITUENT, AGRICULTURAL AND VETERINARY CHEMICAL PRODUCTS October 2004 APVMA PO Box E240 KINGSTON 2604 AUSTRALIA http://www.apvma.gov.au
Selvita Integrated drug discovery collaborations
Selvita Integrated drug discovery collaborations Magdalena Żabka Selvita overview Origins Polish biotechnology research company headquartered in Krakow Mission Resources We deliver comprehensive solutions
EUROPASS DIPLOMA SUPPLEMENT
EUROPASS DIPLOMA SUPPLEMENT TITLE OF THE DIPLOMA (ES) Técnico Superior en Laboratorio de análisis y de control de calidad TRANSLATED TITLE OF THE DIPLOMA (EN) (1) Higher Technician in Analysis and Quality
USP Pharmaceutical Ingredient Supplier Qualification Program. Manual for Participants
USP Pharmaceutical Ingredient Supplier Qualification Program Manual for Participants UNITED STATES PHARMACOPEIA Drug Substance Supplier Qualification Program ICE This manual provides information to drug
OMCL Network of the Council of Europe QUALITY MANAGEMENT DOCUMENT
OMCL Network of the Council of Europe QUALITY MANAGEMENT DOCUMENT PA/PH/OMCL (11) 204 3R HANDLING AND USE OF REFERENCE STANDARDS IN THE OMCL NETWORK Full document title and reference Document type Legislative
Regulation and Risk Management of Combination Products
Regulation and Risk Management of Combination Products Katherine Ulman Associate Scientist Global Regulatory Compliance Manager Dow Corning Healthcare Jim Curtis Senior Specialist, Healthcare Applications
Comparison Chart of FDA and EPA Good Laboratory Practice (GLP) Regulations and the OECD Principles of GLP
Comparison Chart of FDA and EPA Good Laboratory Practice (GLP) Regulations and the OECD Principles of GLP Document issued on: June 2004 U.S. Department of Health and Human Services Food and Drug Administration
Biopharmaceutical Process Evaluated for Viral Clearance
Authored by S. Steve Zhou, Ph.D. Microbac Laboratories, Inc., Microbiotest Division The purpose of Viral Clearance evaluation is to assess the capability of a manufacturing production process to inactivate
Technology Transfer of CMC Activities for MAb Manufacturing. 2010 ge healthcare (www.gelifesciences.com)
M a n u f a c t u r i n g OPERATIONS Technology Transfer of CMC Activities for MAb Manufacturing by Patricia Seymour, Susan Dana Jones, Howard L. Levine With combined 2009 revenues estimated to be over
Guidance for Industry
Guidance for Industry Container and Closure System Integrity Testing in Lieu of Sterility Testing as a Component of the Stability Protocol for Sterile Products For questions on the content of the guidance,
Quality Systems Appropriate for Extemporaneously Prepared Early Phase Clinical Trial Materials. Agenda Topics for Discussion
Quality Systems Appropriate for Extemporaneously Prepared Early Phase Clinical Trial Materials Richard Hoffman, MS Eli Lilly & Co. Principal Consultant - Regulatory PDA/FDA Joint September 20 th, 2011
Journal of Chemical and Pharmaceutical Research
Available on line www.jocpr.com Journal of Chemical and Pharmaceutical Research ISSN No: 0975-7384 CODEN(USA): JCPRC5 J. Chem. Pharm. Res., 2011, 3(2):892-898 World Health Organization s Guidelines for
Introduction to Drug Naming. Angela G. Long, M.S. Senior Vice President, Global Alliances and Organizational Affairs
Introduction to Drug Naming Angela G. Long, M.S. Senior Vice President, Global Alliances and Organizational Affairs What s in a Name? International Nonproprietary Names (INN) Sponsored by World Health
GUIDELINE ON ACTIVE PHARMACEUTICAL INGREDIENT MASTER FILE (APIMF) PROCEDURE 1 (The APIMF procedure guideline does not apply to biological APIs.
15 January 2007 GUIDELINE ON ACTIVE PHARMACEUTICAL INGREDIENT MASTER FILE (APIMF) PROCEDURE 1 (The APIMF procedure guideline does not apply to biological APIs.) TABLE OF CONTENTS 1 INTRODUCTION... 2 2
An Industry White Paper
Driving Continuity and Collaboration from Lab Floor to Plant Floor to Top Floor An Industry White Paper Who is AspenTech? AspenTech is a global company founded in 1981 with more than 1,300 employees in
School of Pharmacy TEMPLE UNIVERSITY
School of Pharmacy TEMPLE UNIVERSITY Regulatory Affairs and Quality Assurance Graduate Program Te mple Unive rsity School of Pharmacy Re gulatory Affairs and Quality Assurance Graduate Program 4 25 Comme
Non-clinical development of biologics
Aurigon Life Science GmbH Non-clinical development of biologics Requirements, challenges and case studies Committed to Life. Sigrid Messemer vet. med. M4 Seminar March 10 th 2014 Aurigon - your full service
CTC Technology Readiness Levels
CTC Technology Readiness Levels Readiness: Software Development (Adapted from CECOM s Software Technology Readiness Levels) Level 1: Basic principles observed and reported. Lowest level of software readiness.
FOOD AND DRUG ADMINISTRATION COMPLIANCE PROGRAM GUIDANCE MANUAL
FOOD AND DRUG ADMINISTRATION COMPLIANCE PROGRAM GUIDANCE MANUAL PROGRAM 7356.002F CHAPTER 56 DRUG QUALITY ASSURANCE SUBJECT: ACTIVE PHARMACEUTICAL INGREDIENT (API) PROCESS INSPECTION Revision Note: Program
POST-MASTER S CERTIFICATES in ADVANCED QUALITY ASSURANCE or REGULATORY AFFAIRS
Temple University - School of Pharmacy 425 Commerce Drive, Suite 175 Fort Washington, PA 19034 Phone: 267.468.8560 Fax: 267.468.8565 POST-MASTER S CERTIFICATES in ADVANCED QUALITY ASSURANCE or REGULATORY
Veterinary Compounding
Veterinary Compounding Veterinarians occasionally use compounded preparations to meet a specific patient s medical need. The purpose of this brochure, created jointly by the Animal Health Institute (AHI),
2015 2016 Ph.D. Science & Engineering Positions. Wilmington, DE. Analytical Sciences Wilmington, DE. Sciences Wilmington, DE.
2015 2016 Ph.D. Science & Engineering Positions 1) Synthetic Organic Chemistry Crop Protection Newark, DE 2) Polymer Chemistry Performance Polymers Various 3) Polymer Engineering Performance Polymers Various
Roles & Responsibilities of the Sponsor
Roles & Responsibilities of the Sponsor Developed by Center for Cancer Research, National Cancer Institute, NIH Endorsed by the CTN SIG Leadership Group Objectives Funding for clinical research comes from
Copyright 2014 The International Pharmaceutical Excipients Council
The International Pharmaceutical Excipients Council Significant Change Guide for Pharmaceutical Excipients Third Revision, 2014 Copyright 2014 The International Pharmaceutical Excipients Council i The
Changes to an Approved Product
Changes to an Approved Product Chemistry, Manufacturing and Controls By Khandan Baradaran, PhD and Peggy Berry, MBA, RAC It is a huge achievement for any company to obtain licensing rights to an approved
Pharmaceutical Quality Systems: US Perspective
Pharmaceutical Quality Systems: US Perspective Rick Friedman Associate Director, Office of Manufacturing and Product Quality Center for Drug Evaluation and Research Topics Background: The ICH Q10 Pharmaceutical
Proficiency Testing In A Global Analytical Environment Benefits & Challenges. AOAC September 2007
Proficiency Testing In A Global Analytical Environment Benefits & Challenges AOAC September 2007 1 The Coca-Cola Company The Coca-Cola Company is the largest manufacturer, distributor and marketer of nonalcoholic
Drug Information Journal, Vol. 33, pp. 755 761, 1999 0092-8615/99
Drug Information Journal, Vol. 33, pp. 755 761, 1999 0092-8615/99 Printed in the USA. All rights reserved. Copyright 1999 Drug Information Association Inc. THE ACTIVE PHARMACEUTICAL INGREDIENTS STARTING
USP CONVENTION MEMBERS BY WORLD REGION
USP CONVENTION MEMBERS BY WORLD REGION April 1, 2015 The 459 organizations listed below are Voting Organizational Members of the U.S. Pharmacopeial Convention (USP). WORLD (8) International Council of
2010 Critical Thinker Series
Malaysian Organisation of Pharmaceutical Industries (MOPI) & PharmEng Technology Presents cgmp Case Studies a T rra ini ing i P rrog rram ffo rr cgmp P rro ffe ss ss ionai l ss 2010 Critical Thinker Series
A FDA Perspective on Nanomedicine Current Initiatives in the US
A FDA Perspective on Nanomedicine Current Initiatives in the US Carlos Peña, PhD Office of the Commissioner FDA September 3, 2010 Outline Context Nanotechnology Task Force report summary Identification
PRODUCT DEVELOPMENT GUIDE
PRODUCT DEVELOPMENT GUIDE PRE-FORMULATION - TABLETS Introduction Guidelines for the development of a ANDA product for the US market, Note: some tests or procedures may be unnecessary. The order of performing
Importing pharmaceutical products to China
Importing pharmaceutical products to China Imported pharmaceutical products need pre-market approval before entering the Chinese market Imported drugs for human use are required to obtain pre-market approval
Regulatory Expectations for GMP: What s Happening. Patricia Weideman, PhD Director, Product Quality & Occupational Toxicology Genentech, Inc.
Regulatory Expectations for GMP: What s Happening Patricia Weideman, PhD Director, Product Quality & Occupational Toxicology Genentech, Inc. Topics Background for changes and expectations of regulatory
Pharmaceutical Auditor Training
www.nsf.org Formerly NSF-DBA The right people. The right solution. The first time. Pharmaceutical or Training Pharmaceutical GMP s and Self-Inspections PQMS or/lead or Training Course A17638 Why Choose
VALIDATION OF ANALYTICAL PROCEDURES: TEXT AND METHODOLOGY Q2(R1)
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE VALIDATION OF ANALYTICAL PROCEDURES: TEXT AND METHODOLOGY
How To Understand The Pharmacology Of The Pharmaceutical Industry
It; MM MODERN Ul NDUSTRY 77 /
Luca Romagnoli, Ph.D. Business Development Manager
Modelli innovativi di produzione per lo sviluppo di un processo altamente qualitativo di farmaci biologici Luca Romagnoli, Ph.D. Business Development Manager BIOLOGICAL DRUGS - SOURCES Monoclonal antibodies
Bioprocessing Media and Buffers Grow with Us
Bioprocessing Media and Buffers Grow with Us Experience Highly experienced media on the selection of standard media as well as development This service packaging, documentation Leading position in single-use
Guidance for Industry
Guidance for Industry Q2B Validation of Analytical Procedures: Methodology November 1996 ICH Guidance for Industry Q2B Validation of Analytical Procedures: Methodology Additional copies are available from:
Considerations in Setting Specifications
EBE Concept Paper Considerations in Setting Specifications March 28, 2013 European Biopharmaceutical Enterprises (EBE), a specialised group of EFPIA Leopold Plaza Building Rue du Trône 108 BE-1050 Brussels
The Use of Enzymes in Dietary Supplements USP Enzyme Workshop July 8, 2009
The Use of Enzymes in Dietary Supplements USP Enzyme Workshop July 8, 2009 Nena Dockery Introduction and History of Use Commercial production of enzymes for use as digestive aids has an extensive history
Media fills Periodic performance qualification (Re-Validation)
Media fills Periodic performance qualification (Re-Validation) Minimum number of Simulations Number of units Contaminated Units Action a Two per Year (Retrospective & Prospective Validation) < 5000 5000
Pharmaceutical Sciences
Is a Career in the Pharmaceutical Sciences Right for Me? Check out our online Student Center to find out more: www.aapspharmaceutica.com/students How do I know if a career in the pharmaceutical sciences
Good Manufacturing Practices: A Synopsis of Their Role and Rationale in Today's Pharmaceutical Marketplace for Tubing
Good Manufacturing Practices: A Synopsis of Their Role and Rationale in Today's Pharmaceutical Marketplace for Tubing Katherine L. Ulman and Dr. Patricia Rafidison Dow Corning Healthcare About the Authors
The Quality System for Drugs in Germany
The Quality System for Drugs in Germany Prof. Dr. Harald G. Schweim Head of Department for Drug Regulatory Affairs Institute for Pharmacy, University of Bonn Former President of the German Federal Institute
Workshop A Design Space (DS)
Implementation of ICH Q8, Q9, Q10 Workshop A Design Space (DS) International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Disclaimer The information
TYPICAL FDA COMMENTS ON IMPURITY PROFILING IN CTD/CEP/DMF SUBMISSIONS
TYPICAL FDA COMMENTS ON IMPURITY PROFILING IN CTD/CEP/DMF SUBMISSIONS By Rajkumar Gupta, Managing Director Perfect Pharmaceutical Consultant Pvt. Ltd and Director Global Institute of Regulatory affairs,
2Technical Support 3Formulation Development 4Proof of Concept 5 GMP Services 6Advanced Drug Delivery 1EUDRAGIT Products Evonik. Power to create.
GMP Services Solutions for Clinical Sample Manufacturing 1 EUDRAGIT Products 2 Technical Support 3 Formulation Development Proof of Concept 4 5 GMP Services 6 Advanced Drug Delivery Evonik. Power to create.
United States Pharmacopeia (USP) Quality Standards for Dietary Supplements. Nandu Sarma, PhD, RPh. Director, Dietary Supplements
United States Pharmacopeia (USP) Quality Standards for Dietary Supplements Nandu Sarma, PhD, RPh. Director, Dietary Supplements ACPM webinar, July 17, 2014 Objectives Describe the dietary supplement regulations
A Preliminary Proposal for a Pharmaceutical Engineering Graduate Program
A Preliminary Proposal for a Pharmaceutical Engineering Graduate Program Planning Committee: Prabir Basu Steve Byrn Ken Morris Rex Reklaitis Paul Sojka Venkat Venkatasubramanian Carl Wassgren National
